Carol J. Levy, MD, CDCES, Named Chief of Endocrinology, Diabetes and Bone Disease at Mount Sinai Health System
Global leader in diabetes technology will guide clinical care, research, and education across Mount Sinai
Mount Sinai Health System has appointed Carol J. Levy, MD, CDCES, as Chief of the Division of Endocrinology, Diabetes and Bone Disease. Dr. Levy has served as interim System Chief since January 2026, bringing together clinical teams and supporting patients, faculty, and trainees.
Dr. Levy is a Professor of Medicine (Endocrinology, Diabetes and Bone Disease), and Obstetrics, Gynecology and Reproductive Science, at the Icahn School of Medicine at Mount Sinai and an internationally recognized diabetes care expert.
Since becoming Director of the Mount Sinai Diabetes Center in 2015, Dr. Levy has worked with colleagues to expand inpatient and outpatient diabetes care, strengthen the clinical team, and increase access to free diabetes education through in-person and virtual programs. Dr. Levy has also served as Associate System Chief for Endocrine Clinical Research since 2022.
Dr. Levy previously led Mount Sinai’s clinical trials office, supporting physicians across internal medicine specialties, including faculty members conducting their first clinical trials. This experience reflects her focus on building research programs and mentoring colleagues at different career stages.
In 2014, she established Mount Sinai’s outpatient artificial pancreas program and has since helped connect diabetes technology research with patient care. Her recent work includes leading a pivotal trial of an automated insulin delivery system for people with type 2 diabetes and coauthoring an international consensus statement on diabetes technology during pregnancy. Her research focuses on translating advances in diabetes technology into patient care.
“Dr. Levy brings a demonstrated ability to unite teams, develop talent, and advance clinical care, research, and education,” said Monica Kraft, MD, Chair of the Department of Medicine, Mount Sinai Health System. “As System Chief, she will build on these strengths in partnership with colleagues throughout the Department of Medicine and beyond, while expanding their impact across the Mount Sinai Health System. I look forward to our continued success together.”
“I am honored that Mount Sinai has entrusted me to lead a division with such a strong tradition of excellence in patient care, research, and education,” said Dr. Levy. “I look forward to continued collaboration with departments across the Health System and the Icahn School of Medicine to build on our strengths, advance cutting-edge clinical research in diabetes and other endocrine conditions, and ensure that our discoveries translate into better outcomes for the communities we serve.”
Dr. Levy has also mentored more than 50 endocrine fellows and junior faculty, developed specialized fellowship training, and supported mentees pursuing publications, national presentations, and academic careers. In 2025, she received the Icahn School of Medicine at Mount Sinai’s Endocrinologist Educator of the Year award. She earned her medical degree at Northwestern University and completed fellowship training at Joslin Diabetes Center and Brigham and Women’s Hospital.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek® and No. 7 in the U.S. on the magazine’s 2026 World’s Best Hospitals list and No. 3 in the world in its World’s Best Smart Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 9 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health grant funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
NIH Funds First Artificial Pancreas Study in the United States for Pregnant Women
Jan 24, 2019 View All Press Releases